يحاول ذهب - حر

Handshake abroad, discord at home

June 09, 2025

|

Business Standard

As multi-party global campaign against Pak-backed terror concludes, Jaishankar picks up the baton with European tour. With some Opposition leaders earning acclaim overseas and winning government's praise, internal party rifts are wide open, especially within Congress. Archis Mohan explains

- Archis Mohan explains

Handshake abroad, discord at home

A high-profile diplomatic offensive launched by New Delhi to rally international opinion in the wake of the Pahalgam terrorist attack and Operation Sindoor concluded on Sunday with the return of the Ravi Shankar Prasad-led 'Group II' from a fortnight-long mission to Europe.

The delegation was one of seven that fanned out globally to expose Pakistan's sponsorship of terrorism and reinforce India's strategic narrative in key capitals.

More than 50 MPs, former diplomats, and ex-Union ministers were dispatched to 33 destinations, including Brussels, home to several European Union (EU) institutions.

The delegations — drawn from across the political spectrum — are expected to brief Prime Minister Narendra Modi in the coming days.

Group II, which included BJP leader D Purandeswari and Shiv Sena (UBT)'s Priyanka Chaturvedi, made stops in France, Italy, Denmark, the United Kingdom, Belgium, and Germany.

The group's return coincided with the Ministry of External Affairs's (MEA's) announcement of External Affairs Minister S Jaishankar's upcoming European tour.

In a statement, the MEA said in the first leg of his tour, Jaishankar will travel to Paris and Marseille in France.

He will also hold talks with his EU counterpart Jean Noel Barrot and participate in the inaugural edition of the Mediterranean Raisina Dialogue in Marseille.

In Brussels, Jaishankar will meet EU High Representative for foreign affairs and Vice-President Kaja Kallas.

المزيد من القصص من Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size